We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Global Pharmatech, Inc., a company develops, manufactures and markets proprietary drugs and nutritional supplements that are based on modernized Chinese medicine and bio-pharmacy, announced that, on April 28, 2006, it has completed the sale of 5,000,000 shares of the company's common stock to Mr. Z.Y. Zhang, a single, non-U.S. and unaffiliated investor for gross proceeds of $5 million.
Tripos, Inc. announced at its annual meeting of stockholders yesterday that its board of directors had reaffirmed its commitment to exploring strategic alternatives to maximize shareholder value and enhance growth prospects for Tripos.
Another four medications, including a drug meant for children, produced by Qiqihar No. 2 Pharmaceutical Co have tested positive for the same toxic chemical as their previously banned medication, Xinhua news agency said today, citing the Heilongjiang Food and Drug Administration.
Israel-based Teva Pharmaceutical has received approval from the U.S. FDA for once-daily Azilect (rasagiline tablets) as a treatment for Parkinson's disease.
AstraZeneca's proposal to buy out Cambridge Antibody Technology Group(CAT) will be reviewed for any potential antitrust violations, the UK Office of Fair Trading (OFT) said.
Pharmaceutical research company Covance has stepped up its laboratory testing capabilities in the Asia Pacific region to satisfy the growing number of sponsors conducting clinical studies in that area, the company reported.
Donor backing for a scheme to save 10 million lives in Africa and Asia by securing finance for vaccination programs is gathering pace with three new countries signing up, a senior official said on Tuesday.
GlaxoSmithKline Plc, Europe's biggest drugmaker, has no intention of quitting Britain, despite threats from animal rights activists, its chief executive said on Wednesday.